Hansen, C. R. (2025) “Eliminating the high-risk CTV1 margin in DAHANCA oropharyngeal radiotherapy: Dosimetric impact on dysphagia and organ-at-risk doses”, Acta Oncologica, 64, pp. 1205–1211. doi: 10.2340/1651-226X.2025.44049.